ClinicalTrials.gg
CompletedNCT05137015Updated Apr 20, 2023

Preventing Injuries in Young Football Players

An interventional study of Injury prevention program in Injury Prevention, sponsored by Universität des Saarlandes. Completed at 1 site in Kosovo. Open to male participants aged 13 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-20.

Sponsored by Universität des Saarlandes · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,027
Allocation
Randomized
Ages
13 Years to 19 Years
Sex
Male
01

Study summary

Football is the most popular sport in the world, with 260 million male and female active participants, including \~113,000 FIFA registered professional players. Playing football is fun and can provide many health benefits, however, it also presents a high injury risk. Studies on elite and non-elite footballers have reported similar injury rates in both genders. The most common football-related injuries are the knee and ankle ligament and thigh muscle strains, Over the past two decades, significant advancement has been made in the field of injury prevention in football. There are used trials to prevent specific injuries, as ankle sprain, ACL injuries, hamstring strains, etc. On the other hand, there are created programs designed to prevent a wider spectrum of injuries like FIFA11+.

Therefore, the aim of this study is to investigate the effect of a new injury prevention program on the overall injury incidence in young football players.

02

Conditions studied

  • Injury Prevention
03

In context

Lead sponsor

Universität des Saarlandes is the lead sponsor of 68 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 19 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

officially registered football club in the football federation of Kosovo players must be between 13-19 years old regular training must take place at least three times per week

Exclusion criteria

Exclusion Criteria:

teams already using an injury prevention program injured players

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
1,027 participants (actual)

Study arms

  • Experimental
    Intervention

    The intervention group will use the new injury prevention program at least twice per week in their training sessions.

    Other: Injury prevention program

  • No intervention
    Control

    The control group will continue their usual training routine.

Interventions

  • OtherInjury prevention program

    The execution of the program takes 10-15 minutes. The program will be performed in the training sessions, after the usual warm-up. The program is based on scientific evidence that has previously shown good efficacy on injury prevention in football. The exercise categories address 7 aspects: 1. Balance 2. Core stability 3. Hamstring eccentrics 4. Glute activation 5. Plyometrics 6. Running 7. Games The games are included with the aim to increase the attractiveness of the program. Each category contains 2 exercises and the coach is free to decide which one to choose in every training session. All exercises are organized in five or six levels with increasing difficulty (physically and cognitively).

06

What researchers measure

Primary outcomes

  1. Overall injury rate

    Time frame: up to 9 months

07

Study locations

1 site
  • University of Gjakova
    Gjakove, Kosovo
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2021 to primary completion in May 2022, 8 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 18, 2021
First posted
Nov 30, 2021
StartActual
Sep 4, 2021
Primary completionActual
May 29, 2022
CompletionActual
Jan 21, 2023
Last update
Apr 20, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 20, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05137015
Lead sponsor
Universität des Saarlandes
Responsible party
Sponsor
First posted
Nov 30, 2021
Start date
Sep 4, 2021
Primary completion
May 29, 2022
Completion
Jan 21, 2023
Last update
Apr 20, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion